For more exclusive content, screens, enhanced profiles, and more, sign up for a free trial of IPO Pro, the platform that gives you all of the IPO...read more
Five IPOs listed this week, all of which raised over $100 million. One direct listing and three SPACs also debuted. Four IPOs and three SPACs submitted initial filings.Leading meat products producer Smithfield Foods (SFD) priced its downsized IPO below the...read more
Drugs Made In America Acquisition, a blank check company targeting pharmaceutical businesses in the US, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one right to receive one-eighth of a share...read more
Drugs Made In America Acquisition, a blank check company targeting pharmaceutical businesses in the US, lowered the proposed deal size for its upcoming IPO on Thursday.The Fort Lauderdale, FL-based company now plans to raise $200 million by offering 20 million...read more
SPACs are back. New issuance is on pace for a 4-year high.
For more exclusive content, screens, enhanced profiles, and more, sign up for a free trial of IPO Pro, the platform that gives you all of the IPO...read more
US IPO Weekly Recap: Active January closes out with several sizable IPOs
Five IPOs listed this week, all of which raised over $100 million. One direct listing and three SPACs also debuted. Four IPOs and three SPACs submitted initial filings.Leading meat products producer Smithfield Foods (SFD) priced its downsized IPO below the...read more
SPAC Drugs Made In America Acquisition prices $200 million IPO, targeting pharma in the US
Drugs Made In America Acquisition, a blank check company targeting pharmaceutical businesses in the US, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one right to receive one-eighth of a share...read more
SPAC Drugs Made In America Acquisition cuts unit offering by 60% ahead of $200 million IPO
Drugs Made In America Acquisition, a blank check company targeting pharmaceutical businesses in the US, lowered the proposed deal size for its upcoming IPO on Thursday.The Fort Lauderdale, FL-based company now plans to raise $200 million by offering 20 million...read more